Tag Archives: Jose Alegre-Martin

Are circulating FGF21 & NT-proBNP promising novel biomarkers in ME/CFS

Posted on 01/05/2021 by wames

Are circulating FGF21 and NT-proBNP promising novel biomarkers in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome?, by Prof Joan Carles Domingo, Dr Begoña Cordobilla, Dr Roser Ferrer, Dr Marina Giralt, Dr Jose Alegre-Martin, and Dr Jesus Castro-Marrero in Antioxidants & Redox Signaling, … Continue reading →

Posted in News | Tagged , , , , , , , , , , | Comments Off on Are circulating FGF21 & NT-proBNP promising novel biomarkers in ME/CFS

Unravelling ME/CFS: Gender‐specific changes in the microRNA expression profiling in ME/CFS

Posted on 04/23/2020 by wames

Unravelling ME/CFS: Gender‐specific changes in the microRNA expression profiling in ME/CFS by Amanpreet K Cheema, Leonor Sarria, Mina Bekheit, Fanny Collado, Eloy Almenar‐Pérez, Eva Martín‐Martínez, Jose Alegre, Jesus Castro‐Marrero, Mary A Fletcher, Nancy G Klimas,  Elisa Oltra, Lubov Nathanson in … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , | Comments Off on Unravelling ME/CFS: Gender‐specific changes in the microRNA expression profiling in ME/CFS

ME/CFS: investigating care practices pointed out to disparities in diagnosis & treatment across European Union

Posted on 12/11/2019 by wames

Myalgic encephalomyelitis/chronic fatigue Syndrome (ME/CFS): Investigating care practices pointed out to disparities in diagnosis and treatment across European Union Elin B Strand, Luis Nacul, Anne Marit Mengshoel, Ingrid B Helland, Patricia Grabowski, Angelika Krumina, Jose Alegre-Martin, Magdalena Efrim-Budisteanu, Slobodan Sekulic, … Continue reading →

Posted in News | Tagged , , , , , , , , , , , , , , , , , , | Comments Off on ME/CFS: investigating care practices pointed out to disparities in diagnosis & treatment across European Union